Pharmabiz39m
New licensing rules mandate compliance with Schedule TB for ASU nasal sprays for patient safety
New licensing rules mandate compliance with Schedule TB for ASU nasal sprays for patient safety: Shardul Nautiyal, Mumbai Friday, January 24, 2025, 08:00 Hrs [IST] The Union minis ...
Pharmabiz39m
AI, telemedicine, remote monitoring transform India’s rural-semi urban healthcare landscape: Sanjay Swain
AI, telemedicine, remote monitoring transform India’s rural-semi urban healthcare landscape: Sanjay Swain: Nandita Vijayasimha, Bengaluru Friday, January 24, 2025, 08:00 Hrs [IS ...
Pharmabiz39m
Panel asks DoP to fix issues related to implementation of PRIP
Panel asks DoP to fix issues related to implementation of PRIP: Gireesh Babu, New Delhi Friday, January 24, 2025, 08:00 Hrs [IST] Identifying that the Promotion of Research and In ...
Pharmabiz39m
MoFAHD reconstitutes Committee for Control and Supervision of Experiments on Animals
MoFAHD reconstitutes Committee for Control and Supervision of Experiments on Animals: Gireesh Babu, New Delhi Friday, January 24, 2025, 08:00 Hrs [IST] The ministry of fisheries, ...
Pharmabiz16h
West Pharma introduces Daikyo PLASCAP RUV closures in new nested format at Pharmapack
West Pharma introduces Daikyo PLASCAP RUV closures in new nested format at Pharmapack: Exton, Pennsylvania Thursday, January 23, 2025, 16:00 Hrs [IST] West Pharmaceutical Services ...
Pharmabiz17h
Solid Biosciences’ AAV-based gene therapy candidate, SGT-212 for Friedreich’s ataxia receives US FDA fast track designation
Solid Biosciences’ AAV-based gene therapy candidate, SGT-212 for Friedreich’s ataxia receives US FDA fast track designation: Charlestown, Massachusetts Thursday, January 23, 2 ...
Pharmabiz15h
US FDA grants breakthrough therapy designation to Bluejay Therapeutics’ brelovitug for treatment of chronic hepatitis delta
US FDA grants breakthrough therapy designation to Bluejay Therapeutics’ brelovitug for treatment of chronic hepatitis delta: Redwood City, California Thursday, January 23, 2025, ...
Pharmabiz20h
ArriVent BioPharma inks exclusive license with Lepu Biopharma for MRG007, an ADC to treat gastrointestinal cancers
ArriVent BioPharma inks exclusive license with Lepu Biopharma for MRG007, an ADC to treat gastrointestinal cancers: Newtown Square, Pennsylvania Thursday, January 23, 2025, 12:00 ...
Pharmabiz19h
Daiichi Sankyo establishes “Smart” Research Laboratory in San Diego to expedite drug discovery
Daiichi Sankyo establishes “Smart” Research Laboratory in San Diego to expedite drug discovery: Tokyo Thursday, January 23, 2025, 13:00 Hrs [IST] Daiichi Sankyo, an innovative ...
Pharmabiz23h
US FDA grants 510(k) clearance and CLIA waiver to Roche’s cobas liat sexually transmitted infection multiplex assay panels
US FDA grants 510(k) clearance and CLIA waiver to Roche’s cobas liat sexually transmitted infection multiplex assay panels: Basel Thursday, January 23, 2025, 09:00 Hrs [IST] Roc ...
Pharmabiz21h
Care Health Insurance introduces customers to the future of health insurance with Ultimate Care
Care Health Insurance introduces customers to the future of health insurance with Ultimate Care: Our Bureau, Bengaluru Thursday, January 23, 2025, 11:30 Hrs [IST] Care Health Insu ...
Pharmabiz17h
Kotak Alternate Asset Managers unveil Rs. 1,600 crore Kotak Life Sciences Fund
Kotak Alternate Asset Managers Limited (Kotak Alt) announced the first close of its Life Sciences Fund, Kotak Life Sciences Fund, a Category II AIF private equity fund. The Rs. 1,600 crore fund has ...